Nuwacell
Latest round
- Series B
Last raised
- Nov 2024
Total raised
- $33M
Investors
- 11
About Nuwacell
Established in 2016 and based in Hefei, China, Nuwacell operates as a biotech company focusing on iPSC technology research and clinical transformation services. It has a branch in Guangzhou. The founder and CSO of the company, Junying Yu graduated from the University of Pennsylvania. The co-founder and CTO of the company, Yin Zhang graduated from the Cornell University. In 2017, the GMP cell laboratory was officially put into operation. The company specializes in biotechnological solutions, focusing primarily on developing innovative drug pipelines across various therapeutic areas. Their core product offerings include the Universal iDAP and Universal Islet therapies, which enhance tissue regeneration and immune response in cancer treatment. These product indications include inflammation repair and tumour immunity for patients with complex diseases. The company's target customer base includes hospitals, research organizations, and pharmaceutical companies. The revenue model of the company is primarily built on B2B transactions with healthcare providers and research organizations. It generates revenue by providing innovative drug pipelines across various therapeutic areas.
Who invested in Nuwacell
11 investors across 2 rounds
See all investors in Nuwacell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuwacell
Who invested in Nuwacell?
Nuwacell has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuwacell raised?
Nuwacell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuwacell last raise money?
Nuwacell's most recent round on record is a Series B, in Nov 2024.
What does Nuwacell do?
Established in 2016 and based in Hefei, China, Nuwacell operates as a biotech company focusing on iPSC technology research and clinical transformation services.
Where is Nuwacell headquartered?
Nuwacell is headquartered in Hefei, China.
Which VCs invest in companies like Nuwacell?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Nuwacell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nuwacell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.